Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes
Publication date: Available online 2 June 2021Source: Annals of Medicine and SurgeryAuthor(s): B.I. Carr, V. Guerra, R. Donghia, S. Yilmaz
Source: Annals of Medicine and Surgery - Category: General Medicine Source Type: research
More News: Cancer & Oncology | Carcinoma | General Medicine | Hepatocellular Carcinoma | Liver Cancer | Thrombosis